

He actively collaborates with scientists at the University of California Santa Barbara, USA Institute of Nano Science and Technology, Mohali, India Gebze Technical University, Turkey Nagoya Institute of Technology, Japan Jilin University, Hubei University, the National Center for Nanoscience and Technology (NCNST, CAS), SUSTech and Shanghai University, China the University of Nottingham, UK IMEC, DuPont Electronics and Imaging, USA. He is currently president of the Pacific Polymer Federation. Professor Whittaker is a member of numerous international committees of governing bodies in polymer science and technology, and is involved in organising major international conferences. His work on polymeric hydrogels including transport properties is highly cited.įinally, Professor Whittaker is an expert in the fundamentals of diffusion process in complex solids and has an international reputation in the field of NMR and MRI of polymeric systems.

He leads research into responsive polymers for nanomedicine and for device manufacture. He is active in developing novel imaging agents for MRI, and has introduced a new class of 19F polymeric agents. In the field of biomaterials science and nanomedicine, Professor Whittaker has established a network of international scientists under the theme “Bringing Materials to Life”. Outcomes include novel high-index resists for 193 nm immersion lithography, new concepts for design of non-chemically amplified resists for EUV lithography, novel approaches to healing roughness in IC features and block copolymer self-assembly. His work in the field of materials for photolithography has been supported by funding from leading semiconductor companies Intel, Sematech, Dow Chemical Company and DuPont. Professor Whittaker’s work in synthesis and characterisation of polymeric materials has underpinned major development programs in several key areas.


He directs research funded through more than $61.3 million in competitive grants since 2000 and $39.7M since 2010. Professor Andrew Whittaker is Deputy Director Research, Senior Group Leader and founder member of the Australian Institute for Bioengineering and Nanotechnology (AIBN).
